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Abstract The need for cancer professionals has never been
more urgent than it is today. Reports project serious short-
ages by 2020 of oncology health care providers. Although
many plans have been proposed, no role for prevention has
been described. In response, a 2-day symposium was held in
2009 at The University of Texas MD Anderson Cancer
Center to capture the current status of the cancer prevention
workforce and begin to identify gaps in the workforce. Five
working groups were organized around the following topic
areas: (a) health policy and advocacy; (b) translation to the
community; (c) integrating cancer prevention into clinical
practice; (d) health services infrastructure and economics;
and (e) discovery, research, and technology. Along with
specific recommendations on these topics, the working
groups identified two additional major themes: the difficulty
of defining areas within the field (including barriers to
communication) and lack of sufficient funding. These inter-
dependent issues synergistically impede progress in prevent-
ing cancer; they are explored in detail in this synthesis, and
recommendations for actions to address them are presented.
Progress in cancer prevention should be a major national
and international goal. To achieve this goal, ensuring the
health of the workforce in cancer prevention and control is
imperative.
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Cancer Prevention: Where Are We Now?
In warning the public about a projected critical shortage of
medical oncologists in the USA by 2020 [1], the 2007 study
commissionedbytheAmericanSocietyforClinicalOncology
(ASCO) stimulated consideration of the unrecognized poten-
tial for cancer prevention efforts by its exclusion from the
report.Italsoraisedconcernthatthefieldofcancerprevention
and control was at risk for a similar workforce shortage in the
future [2]. The ASCO report described factors that contribute
to the impending medical oncology shortage. These include
growth in the number of Baby Boomers at increased risk for
cancer, in the number of oncologists eligible for retirement,
and in the number of cancer survivors with long-term care
needs, as well as the decline in the number of physicians
choosing careers in oncology [1]. Using statistical models to
test various workforce strategies, ASCO reported that given
time and resource constraints for preparing oncologists, sim-
ply training more individuals would not address the shortage
projected for 2020. Clearly, raising concern regarding the
workforce that will manage the future burden of cancer was
not misguided.
Since 2007, much has taken place. Soliciting recommen-
dations to address the shortfall, ASCO created and approved
a strategic plan in 2008 [3]. Some aspects of ASCO’s three-
goal plan have already been implemented. These include
creating a workforce advisory committee [3], providing
grant awards to study workforce issues in partnership with
Susan G. Komen for the Cure Foundation [4], conducting
pilot projects to test innovative practice models and demon-
stration projects to build partnerships between oncologists
and physician extenders [5], and submitting a statement to
the US Senate Health, Education, Labor, and Pensions
Committee hearing on health-care workforce initiatives
[6]. In spite of these steps to address the oncology workforce
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cer through prevention continue to be missed, as most reports
do not consider the impact of cancer prevention activities.
Such omission may result from lack of awareness, skepticism
of the impact of prevention, or the dearth of information
available fordescribingtheinfrastructureofcancerprevention
and control and its workforce [2]. Regardless, if cancer pre-
vention activities are to alleviate the future burden of cancer
on our society, their visibility must be raised.
Lessons from Public Health and Medicine
More than a decade ago, concerns were raised about threats
to the public health workforce [7]. Many of these threats
impeded description of the public health workforce. A mul-
tidisciplinary field that involves many different types of
workers, public health comprises formally trained professio-
nals toindividuals trained on-the-job, makingidentificationof
the individual job descriptions within the workforce difficult
[8].Furthermore,publichealthactivitiesspanbasicresearchto
applied practice and take place in a variety of settings (e.g.,
schools, communities, hospitals, and universities) at different
levels (i.e., local, state, and national). They also involve nu-
merous partners such as governmental agencies, non-profit
foundations, universities, health-care organizations, pri-
vate sector partners, and professional membership societies.
The field of public health has struggled to create a universal,
clearly defined identity for itself, with common language,
goals, and standards. Metrics and infrastructure for workforce
surveillance and forecasting were lacking, which stimulated
enumeration efforts [9]. Since then, important progress has
been made. Motivated by research agendas set for studying
the public health workforce (Table 1)[ 8, 10], a body of
literature now exists that has benefited over time from im-
proved coordination of efforts (e.g., Office of Workforce and
Career Development within Office of the Centers for Disease
Control Director), creation of common definitions, surveillance
of workforce data (e.g., HRSA), development of resources,
methods and models for forecasting and evaluating the public
health workforce, including for policy analysis, as well as
Table 1 Public health workforce research themes and annotations [adapted from Gotway Crawford et al. [8]]
1. Workforce size and composition Measuring, monitoring, and forecasting the workforce size and composition is required for
assessing status and historical trends in workforce size and distribution by age, sex, race/
ethnicity, education, job type, geographical distribution, and experience; and for forecasting
workforce needs, mandating minimal staffing, and allocation of resources. A national,
standardized, and routine surveillance system for classifying and tracking the workforce should
be implemented for use with models to identify ideal distribution of the workforce by venue.
2. Workforce diversity To cultivate positive environments that enhance delivery of public health services, workforce
surveillance data should also include workforce demographic information that facilitates
accommodation of demographic shifts in the workforce and the public when projecting future
workforce demands.
3. Workforce effectiveness and health impact Aworkforce surveillance system should include data and indicators that measure the impact of the
workforce on specific aspects of the public’s health. Other efforts should include long-term
evaluation of training programs and consider the value of credentialing on increasing the quality
and performance of the workforce. Methods need to be developed to evaluate the effectiveness
of workforce policies and strategies to improve the workforce and its impact on achieving
measureable public health outcomes.
4. Recruitment, retention, separation, and
retirement
Developing the strongest workforce relies on understanding which recruitment and retention
strategies are most successful, monitoring trends and key determinants of recruitment and
retention in public health organizations, and knowledge of factors that influence decision-
making in choosing careers in public health.
5. Worker pay, promotion, performance, and
job satisfaction
In addition to needing greater knowledge of the impact of individual-level benefits, organizational
practices, climate, and culture and values that are common to all industries and fields, additional
information is needed about factors that influence satisfaction and stress specific to professionals in
public health.
6. Demand for the public health workforce Methods are needed to measure to the workforce capacity (e.g., size, capability, training, and
resources) at different levels, both currently and in the future, as well as workforce models that
take into account changes that may influence characteristics and composition of the workforce
as well.
7. Education, training, and credentialing the
public health workforce
Identifying measureable core competencies in public health practice has been proposed to increase
individual competency and build workforce capacity, as well as serve as a standard for training
the public health workforce. Certification programs may increase knowledge, skills, abilities,
and competencies, which would also add value and has been implemented in other disciplines
and fields.
8. Public health workforce policy To ensure the sustained impact and effectiveness of the public health workforce, assessing the role
and impact of policies and strategies to improve and change it is critical.
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changes [8]. These challenges to clear characterization of the
public health workforce are similar to those facing cancer
prevention and control today.
Farther along in understanding its workforce, medicine has
maintained a rigorous infrastructure for workforce surveil-
lance through several organizations, including the American
Medical Association, the Association of American Medical
Colleges (AAMC), and the Accreditation Council for Gradu-
ate Medical Education. For example, AAMC has maintained
national databases of medical schools, applicants, students,
graduates, and faculty since 1966. They have described these
resources in terms of their racial and ethnic diversity, gender,
student admissions, and faculty recruitment, retention, sala-
ries, and promotions. The ability of the AAMC to analyze
available data collected annually from more than 130 medical
schools across the USA and Canada has resulted in a rich
literature documenting the health of its workforce from a
variety of perspectives that has kept attention focused on
anticipated workforce shortages in medicine.
Far from being distinct from medicine and public health,
cancer prevention and control shares goals and professionals
with both. However, cancer prevention has unique features
as well. It extends beyond the primary interest of public
health, the health of populations, to include focus upon
individual patients, like medicine. In contrast to public
health and medicine, the field of cancer prevention is spe-
cific in its mission to a single disease around which its
stakeholders can concentrate their efforts, whereas stake-
holders in public health and medicine more often express
their support for specific aspects of public health (e.g.,
vaccinations) or affiliation with specific types of practi-
tioners (e.g., pediatricians), rather than to the broader mis-
sions of public health and medicine at large. Medicine has
articulated competencies that serve as the basis for all train-
ing, board certification, and licensing across the USA. For
the cancer workforce, C-Change, a non-profit organization
oriented to eliminating and preventing cancer, has created
“Cancer Core Competencies” [11, 12], as part of a larger
initiative to address cancer workforce issues, but these compe-
tencies are not widely recognized within the field. Thus, while
much remains to be done in both public health and medicine,
the field of cancer prevention and control can profit from
advances made in these and other fields to understand and
address issues faced by its own workforce.
“The Future Directions in Cancer Prevention
and Control: Workforce Implications for Training,
Practice, and Policy” Symposium
In 2009, a group of cancer prevention and control profes-
sionals organized a 2-day symposium at The University of
Texas MD Anderson Cancer Center, with the objective of
capturing the current status of the cancer prevention work-
force and beginning to identify gaps in the workforce. Five
working groups were organized around topic areas: (a)
health policy and advocacy; (b) translation to the commu-
nity; (c) integrating cancer prevention into clinical practice;
(d) health services infrastructure and economics; and (e)
discovery, research, and technology. Following the sympo-
sium, these groups formed writing groups to develop manu-
scripts about workforce issues relevant to the topic areas.
Trainees attending the symposium through sponsored schol-
arships helped facilitate writing groups and collaborated to
produce a meeting report [13]. A group addressing the
perspective of nurses in cancer prevention was added later,
and the health policy and advocacy group was reorganized
to write the article included in this supplement. In total, six
manuscripts are included in this supplement together with
this synthesis and other materials and information from the
symposium. Each article reflects the perspectives and expe-
riences of the authors and their knowledge of the literature
and available resources. They are offered here as a means to
stimulate dialogue about workforce issues in the field of
cancer prevention and control.
Themes from Writing Groups
In addition to the unique ideas and recommendations pre-
sented in each article, two major themes emerged from the
writing groups: the difficulty of defining areas within the
field (including the barriers to communication and the dif-
ficulties created), and the lack of sufficient funding. These
interdependent themes, along with their sequelae, synergis-
tically impede progress in preventing cancer.
Definitions in Cancer Prevention and Control
The field of cancer prevention and control includes a diver-
sity of disciplines from basic sciences to population-based
research, such as biostatistics, epidemiology, and behavioral
science, as well as a multitude of interventions to be dis-
seminated into community and clinical practice, all of which
are united only by its defining goal—to prevent cancer. The
research in these disciplines varies substantially, by study
design, population focus, or model system (e.g., genetic and
molecular factors, cell lines, animal models, and humans),
by research methods and tools, and by technical language.
Thus, a challenge to professionals within the field is com-
municating across disciplines, especially when different
terms are used to describe similar concepts and when similar
terms have different meanings. The challenge is made more
complex when collaborations involve professionals from
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oriented to the goals or methods of cancer prevention.
Several consequences result from poor communication,
one of the most serious being lack of awareness of potential
cross-disciplinary collaborations. For example, professionals
outside cancer prevention may not realize that their skills and
expertise are relevant to cancer prevention and control. Con-
versely,thoseworkingincancerpreventionmaynotrecognize
the potential gains from collaborating with those outside the
field (or know how to reach them), such as exposure to new
approaches and methods and specialized technology, resour-
ces, and perspectives that could infuse the field with fresh
ideas and energy. Without good communication, those within
the field of cancer prevention and control risk isolation and
missed opportunity for innovative thinking. Moreover, if in-
formation about activities within the field is not communicated
externally,risk for wasteful duplication of resources andefforts
in cancer prevention is greater. Altogether, these consequences
of poor communication slow the pace of discovery and prog-
ress within the field.
Poor communication within the field impedes clear and
uniform definition of emerging areas of focus, a critical
issue for new areas to organize successfully and be nurtured.
For such areas of emphasis to thrive, the individuals in-
volved in those areas must be able to identify one another,
which may be difficult if the fields are labeled differently
(e.g., “cancer prevention health services research” vs. “com-
parative effectiveness in cancer prevention”). Not knowing
about colleagues with similar interests because they describe
themselves differently impedes collaborations, development
of methods and resources, and generation of interest around
the subject matter or topic area. In this era of team science,
rare is the occasion when a major breakthrough is achieved
in isolation. Without commonly defined goals, individuals
may lack orientation to the most critical issues to be
addressed, diluting impact, and progress in cancer preven-
tion. This problem may be especially detrimental to those
early in their careers because junior scientists may compete
more easily for resources in emerging areas than in those
with established experts. If it is difficult for junior scientists
to identify such emerging areas then they cannot take
advantage of them. Clear definitions are also critical for
funding agencies to recognize promising new directions
for cancer prevention, as well as to support training in such
areas. Only once sufficient momentum is gained can more
rapid discovery and advancement be possible, and emerging
areas become established.
The Cancer Prevention Workforce and Poor
Communication
Poor communication affects the cancer prevention work-
force in several ways. First, awareness of the career
opportunities in the field of cancer prevention is lacking
among both students and those who provide career advice
to them. Most students are aware of careers in medicine,
nursing, and public health practice, as well as of careers in
biological, public health, and behavioral science research,
but many may not connect these careers with opportunities
in cancer prevention. Research on the Millenial generation
suggests that young people obtain information about careers
and make career decisions differently than previous gener-
ations, with a focus on initial searches through the Internet, a
preference for “branded” employers and direct contact with
decision-makers in target organizations, and a strong pref-
erence for individualized, tailored career development assis-
tance. Because students ignorant of career opportunities in
cancer prevention will not seek them out, raising the profile
of cancer prevention careers is vital. Unfortunately, exposure
of health professional students to cancer prevention careers
during training remains low. For example, over the past
20 years since efforts by the American Association for Cancer
Education have sought to assess and integrate cancer preven-
tion education into undergraduate medical education, and in
spite of recommendations by the IOM [13], recent review of
medical school curricula suggests only modest success
achieved [14]. Improved efforts to raise awareness among
medical students could have potent impact, as 57% of
entering oncology fellows surveyed by ASCO reported
decidingto pursueoncologybeforeresidency[15].Medical
school represents a critical window of opportunity for influ-
encing physician career choices, as oncology competes with
other subspecialties for those boarded in internal medicine
[16]. Using a variety of strategies, including new methods of
communication (e.g., social media), students must be en-
gaged more effectively and exposed to cancer prevention
careers earlier in their education.
For those already interested in cancer prevention careers,
part of the problem may be structural, in that no clear career
path into the field exists for students to follow. For example,
no specialty or subspecialty is currently dedicated to pro-
viding training in cancer prevention. Medical students hop-
ing to pursue accredited post-graduate medical training
relevant to clinical cancer prevention are limited to choosing
either preventive medicine specialty, which does not focus
exclusively on cancer, or internal medicine subspecialty in
oncology, which does not focus exclusively on prevention.
Some learn about cancer prevention later in their careers,
sometimes after years of practice in basic science and clin-
ical work in oncology. If knowledge of careers in cancer
prevention comes later during the training trajectory, fatigue
from lengthy training or lack of interest in returning to status
as students or trainees may deter some, even if they are
interested in careers in cancer prevention. Moreover, debt
accrued from medical training, while not consistently shown
to influence choice of specialty [17], may discourage those
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if it comes after other required career preparation. The
National Cancer Institute (NCI) is interested in building
the cancer prevention workforce and provides funding for
training and career development awards designed to attract
professionals into research careers in cancer prevention [18].
While these have been successful and have launched the
careers of many researchers, the methods for recruiting
individuals into the field are left to free-market competition.
At any rate, by not creating highly visible and desirable
career paths into cancer prevention and control, we may
already be losing excellent individuals.
Insufficient Funding in Cancer Prevention and Control
A second major barrier to achieving success in cancer pre-
vention and control that the writing groups cited often was
insufficient funding. Indeed, in 2010, while the NCI spent
31.7% for research in cancer causation, detection, and diag-
nosis and 22.7% for treatment research, a total of 7.1% of
the NCI annual budget was allocated for cancer prevention
and control [19]. This reflects a decreasing trend over time
in the proportion of the total budget for funds specifically
allocated for cancer prevention and control, which was
10.7% in 2006, 10.4% in 2007, and 9.9% in 2008 before
the budget mechanism for cancer prevention and control
was eliminated altogether in 2009. Of course, the NCI is
not the only source of funding for cancer prevention and
control activities. Many other federal agencies and philan-
thropic organizations, both large and small, contribute to
supporting activities to prevent cancer. In spite of these
collective efforts, progress in cancer prevention and control,
regardless of funds expended, remains moderate at best.
The perception of the writing groups that insufficient
funding forms a major barrier to cancer prevention is natural
given the breadth of disciplines within the field, and the
wide scope of activities and their complexity that fall under
the rubric of cancer prevention and control. For research, the
ability to pursue more ambitious goals at a faster pace than
in past has been facilitated by major advances in technology,
including computing, robotics, and faster, easier to use, and
omnipresent tools for communication. These have increased
the pace of research, but not always decreased its cost.
Moreover, discoveries in cancer prevention research that
are translated into effective interventions may have associ-
ated costs as well, such as for procedures, for tests or assays,
or personnel effort and time to deliver educational and
behavioral change strategies. Of course, the more intractable
that major cancer risk factors are, such as inherited suscep-
tibility to cancer, tobacco use, and obesity, the greater the
resources needed to address them successfully may be, but
also the more the professional community and the public
may want efforts redoubled. Gaining headway against such
risk factors may be especially challenging due to the com-
plex etiology of these conditions. Of course, cancer preven-
tion professionals endure constant pressure from the public’s
desire for easy and low-cost methods to prevent cancer with
little or no side-effects.
A long-standing problem to clinical implementation of
proven cancer prevention strategies has been limited reim-
bursement for conducting cancer prevention activities. The
proportions of oncologists reporting “insufficient reimburse-
ment for prevention activities in clinical practice” as a
barrier to cancer prevention did not change substantially,
from 65% to 63%, in the 15 years between surveys con-
ducted in 1989 and 2004 [20, 21]. Such a report is disap-
pointing in light of the advances in cancer prevention
achieved to date. Other advances pose cost-related chal-
lenges as well. For example, the exciting results in 2011
demonstrating the effectiveness of CT screening for lung
cancer early detection reported from the National Lung
Screening Trial [22] raises many cost-related issues about
who should be screened and how often, as well as whether
the cost of regular screening will be prohibitively expensive
and who will pay for it [23]. It is to be expected that policies
to reimburse for specific cancer prevention services will
always lag behind the development of scientific discoveries
into tools that are proven effective; however, the decision-
making process by which policy makers, patient advo-
cates, insurers, and health-care providers determine
which services to include in cancer prevention coverage
may need improvement in order to have greater impact on
the burden of cancer [13].
Funding for Training the Cancer Prevention Workforce
Funding for recruiting and preparing the professional work-
force in cancer prevention and control exists. In 2010, the NCI
allocated 3.5% ofitsannual budget ($179,346,000)to research
manpower development [19]. This amount encompasses sup-
port for all research training in cancer, including for cancer
preventionand controlscientists. Of the17extramural training
and educational award mechanisms listed on the NCI’sC e n t e r
for Cancer Training’s website, three specifically provide sup-
port for individuals and one for institutions to support multiple
trainees in cancer prevention research training. The total
amount in 2010 for individual awards was $21.4 M (21 K05
awards at $3.1 M; 97 K07 awards at $13.3 M; and 30 K05
awardsat$5.0M) andforthe44 institutional R25Tawards, the
total amount was $20.4 M [24], equaling 23.3% for cancer
preventionofthetotal amount spent by NCI on developingthe
research workforce. The NCI portfolio comprises only a por-
tion of the support expended in the USA for training and
education in cancer prevention and control; other arms of the
NIH, other federal agencies (e.g., AHRQ, DOD, and CDC),
non-profit foundations (e.g., American Cancer Society,
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panies also provide support for training and education in
cancer research. In 2001, the American Cancer Society esti-
mated that approximately 20% of its total spending in training
and career development was dedicated to cancer prevention,
between $2 and $3 M annually [13]. In Texas, the Cancer
Prevention and Research Institute of Texas (CPRIT) has
funded350awardssince2010formorethan$570M,ofwhich
12 of 27 were in prevention education, for a total of $5.5 M.
This amount represents 57% of the total $9.7 M awarded for
prevention activities or 0.97% of all CPRIT funds
awarded to date [25]. To recruit and retain individuals
in cancer careers, a recent partnership between the Amer-
ican Society for Clinical Oncology and the Susan G.
Komen for the Cure Foundation provides loan repayment
for oncologists from populations underrepresented in
medicine committed to serving medically underserved
communities [26, 27].
The availability of such funds represent a major commit-
ment to preparing the next generation of cancer professionals;
however, it is unclear whether the total amount of funds
dedicated to training cancer prevention professionals—either
in Texas or across the nation—is sufficient to staff and serve
the growing needs for cancer prevention and control, par-
ticularly in proportion to other public health issues. Indeed,
one indicator that funding may be insufficient comes from
the long-standing and alarming steady decline in numbers
of physicians serving in public health leadership [13]. Also,
residency programs in preventive medicine are shrinking,
both in total number, from 90 programs in 1999 to 72 in
2012, and in the annual number of residents in training,
down15%since2001[28,29],partlybecausenearlyhalfof
available training positions are left unfilled due to insuffi-
cient funding [30]. Supporting residency programs in pre-
ventive medicine is particularly challenging. Unlike all
other residency programs that qualify for support from
Medicare Graduate Medical Education because they are
hospital based, preventive medicine residency programs
do not receive Medicare funding because preventive med-
icine residents are typically trained outside hospitals [30].
While graduate medical training in both preventive medi-
cine and oncology includes some exposure to cancer pre-
vention and control, overcoming the challenges to funding
training in prevention for health-care providers is critical to
having sufficient numbers in the cancer prevention and
control workforce.
In spite of the funding awarded to date for training in
cancer prevention and control, the writing groups opined
that too few training programs in cancer prevention and
control existed overall, and that too few existed to populate
specific areas of need within the field. Indeed, in 1999, the
NCI reshaped the focus of its R25T award program in
response to its perceived need to populate cancer research
with professionals prepared to participate in multidisciplin-
ary research [13]. This award mechanism is well-suited to
the types of cross-disciplinary projects and environments
that are the norm in cancer prevention and control, and has
facilitated a more vigorous effort to recruit researchers into
the field. Of the 43 awards active in 2010, 22 allow for
research training in a variety of areas within cancer preven-
tion and 11 focus on specific aspects, such as behavioral
science, nutrition, genetics, or tobacco [24]. Such programs
provide fellowship support for those learning how to con-
duct research in cancer prevention through basic science,
population and behavioral science, and clinical translation.
The R25T programs differ from other NIH-funded training
programs (e.g., Kirschstein NSRAT32 awards) in that they
require trainees to have a minimum of two mentors with
complementary expertise to facilitate development of cross-
disciplinary research skills (NCI R25T PAR-10-165). Care-
ful nurturing of trainees preparing for such multidisciplinary
careers is required if the educational and research experien-
ces provided are not to revert to uni-disciplinary training or
to be diluted by countervailing mentoring, institutional, or
other environmental factors antagonistic to multidisciplinary
approaches [2].
To supplement the recruitment of new cancer prevention
researchers, some writing groups described a need to provide
supplementary training in cancer prevention to professionals
who are already established in their careers, a recommenda-
tion espoused in the IOM’sr e p o r t ,“Fulfilling the Potential for
Cancer Prevention and Early Detection” [13]. Several state
cancer plans include providing cancer prevention education
for a variety of health-care providers [31]. However, the state
cancer plans vary in support received, and the amount of state
funding expended for strengthening the cancer prevention
workforce and its impact are unknown. Funding is available
for workshops that focus on “novel cancer-focused state-of-
the-art research or methodological knowledge, or evidence-
based cancer prevention and control interventions” through
the NCI R25E award mechanism (PAR-12-049), although
funds are not specifically targeted for health-care providers
a n dw o u l df o c u so nt h e mo n l yi fp r o p o s e dt od os ob y
sponsoring institutions. Awards are granted for up to 5-years
at $300,000/year in direct costs and are not renewable,
which may limit the long-term impact of cancer prevention
training for providers if sponsors are unable to sustain
developed programs after NCI funding ends. One cancer
prevention education resource available to physicians for
purchase was developed by the American Society for
Clinical Oncology (ASCO): “Cancer Prevention Curricu-
lum” bookand CD ROM, and its maintenance module [32];
offering up to 28.5 h of CME credit, the book and CD cover
a wide range of topics organized into 27 chapters, including
tobacco, diet, screening, chemoprevention, community
interventions, ethics of clinical trials, survivorship, and
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meeting, ASCO has created a track to feature research and
education in cancer prevention. Oncologists and primary
care physicians alike recognize the need to deliver cancer
prevention services to their patients [33] as together, they
coordinate the long-term care for increasing numbers of
cancersurvivorsandthoseatriskforcancer.However,even
practicing oncologists report a need for more information
a n dt r a i n i n gt oi n c r e a s ec o n f i d e n c ei nd e l i v e r i n gc a n c e r
prevention and control care more effectively to their
patients [20, 34]. Thus, the critical challenge then becomes
how to reach ASCO members and beyond to other health-
care providers, to provide training in cancer prevention to
improve coordinated care, as well as how to pay for it [1].
Other Issues for Future Consideration
Critical issues remain for future consideration. For example,
in the USA, educators currently struggle to attract students
into research careers in general. Negative perceptions of
features of science careers such as low salaries, long hours,
little recognition, and high competition do little to draw
interest. This problem is compounded by lack of awareness
of careers opportunities in science, let alone for careers in
cancer prevention. Also unknown is the impact of changing
preferences in work expectations on recruiting and retaining
the future cancer prevention workforce. Gen X, Millennials,
and younger generations have different lifestyle and work
priorities from their parents and earlier generations, such
that new strategies are needed to accommodate generational
differences. At the same time, the fierce competition for
funding in the sciences demands ever increasing effort from
researchers. It is not clear how these conflicting trends can
be reconciled.
The academic health science centers environment in
which research takes place, including for cancer prevention,
is not appealing to many faculty, younger or older, and
makes retention and reward additional challenges. Many,
even established, faculty struggle to maintain productivity
in the face of increasing administrative demands, while
accommodating other professional and personal needs.
Careers in academia are not widely perceived as enjoyable
or worth the effort, and efforts to change the toxic environ-
ment are not on the horizon. NIH has made some important
changes to allow more individuals to gain recognition for
their work in the form of multiple PI-led grant awards, and
journals recognize co-first authored articles. However, the
ratio of tenure-track positions to those who aspire to them
remains problematic. Generational culture change,
decreases in funding levels, the paucity of secure faculty
positions, and the explosive pace of scientific and techno-
logical advances have come together in a sort of perfect
storm, dramatically increasing the volume of work to be
done while decreasing the number of researchers available.
Creative solutions to address these issues will be essential
for building and retaining the future cancer prevention
workforce.
One important moderator of the trend toward a decreas-
ing workforce is the internationalization of scientific re-
search. Thousands of scientists from around the world are
coming to the USA for training and research (as well as
working in their home countries) and making substantial
contributions to cancer prevention research. The total num-
ber of foreign scientists and engineers working in academia
in the USA has more than doubled in the past 35 years [35],
and non-US citizens have constituted more than half of the
US biosciences postdoctoral population since 2004 [36].
The influx of international scientists helps to mitigate
decreases in the research workforce. At the same time,
however, immigration restrictions, cultural and linguistic
barriers in academia, and growth in some foreign econo-
mies, such as China’s, induce many of these researchers to
return to their home countries. But given the projected
increases of cancer incidence and mortality worldwide
(27% and 45% according to WHO) [37], the need for cancer
prevention efforts around the world will be of crucial im-
portance, and cancer prevention efforts must be relevant to
the types and causes of cancers found in various geograph-
ical regions, infrastructures and economic environments,
and cultural landscapes. This is especially true of cancers
that are preventable by behavior change, which will require
specialized, culturally appropriate interventions. Thus, well-
trained researchers in cancer prevention are needed around
the world. Future efforts for the cancer prevention work-
force must not neglect this critical topic.
The Need for a National Cancer Prevention Workforce
Plan
Some gaps in the cancer prevention and control workforce
have already been identified. For example, the National
Cancer Registrar Association has reported anecdotal evi-
dence for shortages in the professionals who manage and
staff tumor registries that are critical for cancer surveillance.
Feedback from a 2006 workforce survey indicated unfilled
or difficult to fill registrar positions that vary by type of
position and geographic region [38]. Other shortages are
more difficult to quantify, but increasing job opportunities
in cancer prevention have been reported [2]. To support
health science training and education across the country,
the NIH has used funding mechanisms that vary in scope
and size. Some are broad and support a wide range of
disciplines for professional training. Others are narrower in
focus, in order to facilitate targeted recruitment of
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This system has prospered through free-market competition
of institutions and individuals.
Benefits of using an open competition system to establish
health science training and education are several. They
include providing equal opportunity to compete for resour-
ces and the freedom to determine how best to address the
workforce needs that they perceive, taking advantage of the
unique strengths of their sponsoring institutions and leaders.
Indeed, minimal requirements imposed by funding agencies
allow programs to range in size and approach, maximizing
the fit of training programs to particular research niches
within the field. Many large health science centers have
competed successfully for training program support, taking
advantage of greater capacity and existing infrastructure.
Disadvantages to free competition exist as well. For
example, unguided proliferation is likely to create a hodge-
podge of programs that duplicates efforts and resources,
leaving gaps unaddressed. As expanding training activities
where programs or expertise already exist does not broaden
the workforce where it is needed, funding agencies may be
discouraged from supporting new training programs, whether
they are of equal quality or better than existing ones. Also,
training resources often go to large research centers that have
other assets and advantages for sponsoring educational activ-
ities, but smaller centers may have greater need to develop
expertise. The latter may not compete well, having disadvan-
tages that are difficult to overcome without funding support
that then becomes a self-perpetuating problem. This may help
explain why several states in the Midwestern United States do
not have NCI-designated comprehensive cancer centers or
NCI-funded training programs, as gaps may occur either in
topic or by geographic region, or both. Another disadvantage
is the amount of time needed for training relative to the
urgency of addressing shortages. While some professions
can train large numbers of individuals quickly for positions
that require less education and training [16], other pro-
fessions that require more intensive preparation may not
be able to mobilize sufficiently fast if needs are urgent.
In general, the free-market competition of applicants to
the NIH for training and education funds, while advantageous
in some respects, is problematic in others. The disparities
could be addressed by developing a national cancer preven-
tion workforce plan.
Forming a National Cancer Prevention Workforce Plan
Three resources are needed to create and implement a na-
tional cancer prevention workforce plan: leadership, data,
and commitment for sustained support in cancer prevention
and control. Leadership is needed both to recognize the role
that cancer prevention and control can play in reducing the
burden of cancer and to champion the need to nurture and
maintain a health workforce to sustain cancer prevention
activities. Such leadership must facilitate identification of
workforce needs in the field of cancer prevention and con-
trol and define the goals to address them. Leaders are also
needed to ensure that sufficient resources are made available
to sustain the workforce, to oversee implementation of
needed changes and the evaluation of their impact, and to
maintain as a priority developing and strengthening the
workforce in cancer prevention and control. Leadership is
needed from a variety of stakeholders, including research
and clinical leaders in the field, funding agencies, and pro-
fessional membership societies who have interest in devel-
oping their membership, as well as patient groups and
communities who are direct consumers of cancer prevention
services.
Another major building block in creating a national
workforce plan is data about the cancer prevention work-
force, both current workers and those in training. Metrics of
the workforce would allow surveillance for emerging areas
of need and prevention of workforce shortages. Without
metrics for measuring and models for forecasting, it
becomes impossible to determine whether the workforce
will be sufficiently prepared to meet future needs in cancer
prevention and control. Interviews with cancer center direc-
tors suggest that many centers may not track staffing metrics
in ways that facilitate workforce monitoring [39]. Valuable
information for evaluating training and education activities
includes long-term career tracking of those who have re-
ceived funding as well as those who did not. Such data may
be available for trainees, current and former, who received
funding from the NIH, but only to NIH staff. Ultimately,
even the best plans are doomed if long-term commitment is
not secured.
Ideally, a national cancer prevention workforce plan
would include several elements. First, an inventory should
be taken of existing training and educational resources in
cancer prevention and control followed by a list of work-
force gaps, either identified or shortly anticipated. The in-
ventory and list would be organized by career stage and type
of profession or discipline, and include topics and geograph-
ic areas for targeted resources. Next would be a plan for
short-term management of the workforce, which would
strengthen productive programs, reduce or eliminate unnec-
essary resources, and propose strategies to address short-
ages. A final section would describe long-term strategies for
surveillance and evaluation of the workforce, anticipation of
its needs, and prevention of shortages. For oversight and
implementation of plans, roles for stakeholders would need
to be specified—for individuals, professional societies, uni-
versities and professional schools, funding agencies, and
systems at large that prepare and influence resources for
developing the workforce. Preferably, efforts on behalf of
the cancer prevention workforce would be performed in
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Change’s major initiatives is to engage the corporate sector
in cancer prevention activities through employer-sponsored
health plans [40]. The CEO-Roundtable on Cancer is anoth-
er non-profit organization that uses an accreditation system
to engage employers in sponsoring prevention activities
[41]. In the end, whatever strategies are used should employ
the best attributes of an open competition system, while also
incorporating mechanisms to provide sufficient guidance to
manage the workforce without being overly proscriptive or
inflexible.
Risk of the Status Quo
The likelihood is good that the current system for sponsor-
ing the training and education of the future workforce in
cancer prevention will continue to serve, but perhaps only
adequately so. NIH program officers and their advisors can
use the tools they currently have available to shape training
and education resources and minimize duplication of efforts;
they can choose judiciously from among proposed programs
winnowed through the peer-review process, and develop
program announcements to direct interest to specific areas
of need and interest. However, these are blunt tools for
managing the workforce in cancer prevention effectively
and the risk for failure is substantial when borne without
the benefit of comprehensive surveillance data and guidance
from regular feedback from those in the field. Existing gaps
may continue to be unaddressed and new ones go unnoticed;
when gaps are detected, the system may be sluggish in its
response to meet workforce needs [16]. Mobilizing resour-
ces, recruiting individuals for training, and preparing them
for careers in cancer prevention and control take time and
effort, often years before professionals are ready to launch
their careers. Thus, in the absence of a clearly articulated
strategic plan that enjoys the endorsement of multiple stake-
holders, our ability to train and prepare the workforce ade-
quately to meet changing public health needs in cancer
prevention and control remains in peril.
Summary
All indicators suggest that the need for efforts to prevent
cancer will only increase. The numbers of individuals who
can benefit from prevention services, including those al-
ready diagnosed with cancer or at risk for cancer, has
grown over time. Regardless of the number or difficulty
of the challenges, we should not allow ourselves to lapse
into contentment with the current pace of preventing can-
cer. Given the amazing strides in the past 50 years against
other major causes of death such as stroke, influenza, and
cardiovascular disease, as well as those against HIV/AIDS
in the past 30 years, progress against cancer and its pre-
vention should be a major national and international goal.
To achieve this goal, ensuring the health of the workforce
in cancer prevention and control is imperative.
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